These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8676200)

  • 1. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
    Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123I]iodo-2'deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Bonini R; Di Luca L; Buralli S; Bonora D; Ricci S; Baranowska-Kortylewicz J; Adelstein SJ; Falcone A; Kassis AI
    Acta Oncol; 1996; 35(7):941-5. PubMed ID: 9004775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
    Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases.
    Sgouros G; O'Donoghue JA; Larson SM; Macapinlac H; Larson JJ; Kemeny N
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1177-83. PubMed ID: 9719130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled iododeoxyuridine: safety evaluation.
    Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
    J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
    Kassis AI; Adelstein SJ
    Acta Oncol; 1996; 35(7):935-9. PubMed ID: 9004774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
    Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
    J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine.
    Tjuvajev JG; Macapinlac HA; Daghighian F; Scott AM; Ginos JZ; Finn RD; Kothari P; Desai R; Zhang J; Beattie B
    J Nucl Med; 1994 Sep; 35(9):1407-17. PubMed ID: 8071684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.
    Rösler TW; Matusch A; Librizzi D; Arias-Carrión O; Freundlieb N; Hoeffken H; Oertel WH; Depboylu C; Höglinger GU
    PLoS One; 2014; 9(7):e102397. PubMed ID: 25028935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
    Kinsella TJ; Kunugi KA; Vielhuber KA; McCulloch W; Liu SH; Cheng YC
    Cancer Res; 1994 May; 54(10):2695-700. PubMed ID: 8168099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
    Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
    J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swine.
    Baranowska-Kortylewicz J; Dalrymple GV; Harrison KA; Holdeman KP; Sharp JG; Cohen SM; Lieberman RP; Schneiderman MH; Clausen SR; Hoffman D; Lai J; Schneiderman GS; Helseth L
    Acta Oncol; 1996; 35(7):925-33. PubMed ID: 9004773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
    Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
    Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.